Finance

Lists
Why is PPLPHARMA up 3,55%?
Dive Deeper
PPLPHARMA:NSE
Piramal Pharma Ltd (Mumbai)
247,10 INR
+3,55%
(+8,47) 1D
8 ნოე, 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PPLPHARMA...
Open
238,80 INR
High
240,00 INR
Low
235,12 INR
Mkt. cap
324,95 მლრ.
Avg. vol.
8,45 მლნ.
Volume
0,00
52-wk high
243,20 INR
52-wk low
132,30 INR
EPS
-1,58 INR
No. of employees
7 ათ.
Open
238,80 INR
High
240,00 INR
Low
235,12 INR
Mkt. cap
324,95 მლრ.
Avg. vol.
8,45 მლნ.
Volume
0,00
52-wk high
243,20 INR
52-wk low
132,30 INR
EPS
-1,58 INR
No. of employees
7 ათ.
News stories
From web sources and news partners
About Piramal Pharma Ltd (Mumbai)
CEOპიტერ დეიონგ
Employees7,12 ათ.
Founded2020
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitepiramalpharma.com
Last report
28 ოქტ. 2026
Fiscal period
Q2 2027
0,04 INR / -0,38 INR
+110,57%beat
Revenue / Est. (INR)
26,17 მლრდ. / 23,58 მლრდ.
+11,00%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
21,40 მლრდ.
27,52 მლრდ.
22,70 მლრდ.
26,17 მლრდ.
Cost of goods sold
7,86 მლრდ.
13,95 მლრდ.
8,52 მლრდ.
9,06 მლრდ.
Cost of revenue
7,86 მლრდ.
13,95 მლრდ.
8,52 მლრდ.
9,06 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,00 მლრდ.
8,19 მლრდ.
6,76 მლრდ.
7,14 მლრდ.
Operating expense
13,71 მლრდ.
11,09 მლრდ.
14,46 მლრდ.
15,95 მლრდ.
Total operating expenses
21,57 მლრდ.
25,04 მლრდ.
22,98 მლრდ.
25,01 მლრდ.
Operating income
-170,10 მლნ.
2,47 მლრდ.
-283,50 მლნ.
1,16 მლრდ.
Other non operating income
432,40 მლნ.
-977,90 მლნ.
894,10 მლნ.
359,30 მლნ.
EBT including unusual items
-938,60 მლნ.
430,00 მლნ.
-74,60 მლნ.
816,30 მლნ.
EBT excluding unusual items
-527,50 მლნ.
1,40 მლრდ.
-74,60 მლნ.
816,30 მლნ.
Income tax expense
423,30 მლნ.
518,30 მლნ.
619,30 მლნ.
766,00 მლნ.
Effective tax rate
-45,10%
120,53%
-830,16%
93,84%
Other operating expenses
5,58 მლრდ.
723,30 მლნ.
5,47 მლრდ.
6,48 მლრდ.
Net income
-1,36 მლრდ.
-88,30 მლნ.
-693,90 მლნ.
55,80 მლნ.
Net profit margin
-6,36%
-0,32%
-3,06%
0,21%
Earnings per share
-0,72
1,32
-0,52
0,04
Interest and investment income
-
70,70 მლნ.
-
-
Interest expense
-892,40 მლნ.
-805,40 მლნ.
-880,80 მლნ.
-876,30 მლნ.
Net interest expenses
-892,40 მლნ.
-734,70 მლნ.
-880,80 მლნ.
-876,30 მლნ.
Depreciation and amortization charges
2,13 მლრდ.
2,18 მლრდ.
2,24 მლრდ.
2,33 მლრდ.
EBITDA
1,68 მლრდ.
4,32 მლრდ.
1,57 მლრდ.
3,29 მლრდ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები